Nephrocare Health Services Key Ratios
NSE: NEPHROPLUS | BSE: 544647
₹733.45
₹-10.65
(-1.43%)
As on 09-Sep-2026IST
Market cap
₹7,372 Cr
Revenue (TTM)
₹999 Cr
P/E Ratio
95.9
P/B Ratio
6.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 6.08 | 23.69 | 32.16 | 31.70 | -- |
| EBIT | 40.90 | 40.28 | 44.74 | 329.85 | -- |
| Net Profit | 5.28 | 34.89 | 14.52 | 104.23 | -- |
| EPS | 5.28 | -75.68 | -89.93 | 36.89 | -- |
| Book Value | -- | -- | -82.99 | -36.79 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 11.34 | -- | 13.65 | 12.46 | 7.91 |
| Net Margin
| 7.45 | -- | 7.51 | 8.71 | 6.11 |
| Return on equity
| 10.68 | -- | 9.22 | 13.81 | 9.00 |
| Return on Capital
| 13.18 | -- | 16.18 | 14.76 | 8.59 |
| Return on Assets
| 6.30 | -- | 6.37 | 7.63 | 4.91 |
| Debt to Equity (x)
| -- | -- | 0.02 | 0.40 | 0.60 |
Profitability
ROCE
16.18
Lower than Peers by 3.73
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
16.18
|
14.76
|
8.59
|
1.31
|
--
|
|
Peer Median
|
19.91
|
20.26
|
19.83
|
33.53
|
--
|
ROE
9.22
Lower than Peers by 5.24
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
9.22
|
13.81
|
9.00
|
-3.13
|
--
|
|
Peer Median
|
14.46
|
13.93
|
15.80
|
26.65
|
--
|
ROA
6.37
Lower than Peers by 2.32
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
6.37
|
7.63
|
4.91
|
-1.81
|
--
|
|
Peer Median
|
8.69
|
10.00
|
8.30
|
16.54
|
--
|
EBIT Margin
13.65
Lower than Peers by 6.91
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
13.65
|
12.46
|
7.91
|
0.39
|
--
|
|
Peer Median
|
20.56
|
19.66
|
18.70
|
19.68
|
--
|
Net Margin
7.51
Lower than Peers by 4.34
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
7.51
|
8.71
|
6.11
|
-2.66
|
--
|
|
Peer Median
|
11.85
|
11.96
|
12.26
|
16.78
|
--
|
Cash Profit Margin
16.77
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
16.77
|
18.47
|
16.12
|
8.02
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
32.16
Higher than Peers by 10.62
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
32.16
|
33.50
|
29.47
|
--
|
--
|
|
Peer Median
|
21.53
|
15.74
|
13.67
|
4.18
|
--
|
EBIT Growth
44.74
Higher than Peers by 21.10
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
44.74
|
110.32
|
2,509.15
|
--
|
--
|
|
Peer Median
|
23.64
|
22.60
|
11.16
|
-14.65
|
--
|
Net Profit Growth
14.52
Lower than Peers by 8.42
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
14.52
|
90.98
|
398.02
|
--
|
--
|
|
Peer Median
|
22.94
|
23.29
|
9.39
|
-16.12
|
--
|
EPS Growth
-89.93
Lower than Peers by 91.79
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
-89.93
|
89.25
|
396.48
|
--
|
--
|
|
Peer Median
|
1.87
|
29.43
|
-7.32
|
-35.05
|
--
|
Book Value Growth
93.44
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
93.44
|
40.59
|
7.11
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.02
Higher than Peers by 0.00
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
0.02
|
0.40
|
0.60
|
0.52
|
--
|
|
Peer Median
|
0.02
|
0.05
|
0.08
|
0.15
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
0.01
|
0.17
|
0.22
|
0.24
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.80
Higher than Peers by 0.17
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
2.80
|
1.92
|
1.61
|
1.86
|
--
|
|
Peer Median
|
2.63
|
2.42
|
2.28
|
1.88
|
--
|
Quick Ratio
2.69
Higher than Peers by 0.12
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
2.69
|
1.83
|
1.50
|
1.71
|
--
|
|
Peer Median
|
2.57
|
2.37
|
2.33
|
1.78
|
--
|
Interest Coverage
2.62
Lower than Peers by 5.34
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
2.62
|
5.20
|
2.64
|
0.47
|
--
|
|
Peer Median
|
7.95
|
7.61
|
10.16
|
11.52
|
--
|
Operating Efficiency
Debtors to sales
31.73
Higher than Peers by 22.36
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
31.73
|
35.25
|
35.80
|
36.25
|
--
|
|
Peer Median
|
9.37
|
10.62
|
7.60
|
14.45
|
--
|
Asset Turnover
0.83
Lower than Peers by 0.04
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
0.83
|
0.86
|
0.79
|
0.67
|
--
|
|
Peer Median
|
0.87
|
0.81
|
0.77
|
0.86
|
--
|
Receivable days
106.58
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
106.58
|
113.27
|
116.42
|
132.30
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
10.90
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
10.90
|
12.69
|
16.82
|
21.93
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
205.92
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
205.92
|
172.42
|
123.18
|
110.84
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-88.44
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
-88.44
|
-46.47
|
10.06
|
43.39
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
66.02
Higher than Peers by 1.60
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
66.02
|
--
|
--
|
--
|
--
|
|
Peer Median
|
64.42
|
59.48
|
60.28
|
46.86
|
--
|
Price / Book Value
4.62
Lower than Peers by 4.17
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
4.62
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.78
|
9.63
|
8.84
|
6.59
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.14
|
0.04
|
0.42
|
0.38
|
--
|
EV/EBITDA
19.25
Lower than Peers by 30.65
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
19.25
|
0.42
|
1.71
|
3.43
|
--
|
|
Peer Median
|
49.89
|
48.17
|
47.88
|
27.71
|
--
|
Market Cap
5,073
Lower than Peers by 7,413
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Nephrocare Health Services
|
5,073
|
--
|
--
|
--
|
--
|
|
Peer Median
|
12,486
|
8,622
|
9,694
|
5,629
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
